©The Author(s) 2024.
World J Gastrointest Surg. Jul 27, 2024; 16(7): 2255-2269
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2255
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2255
Table 1 Baseline characteristics, surgical and oncological data, n (%)
| Variable | n = 110 |
| Demographics | |
| Sex | |
| Male | 91 (82.7) |
| Female | 19 (17.3) |
| Age (years) | 64.47 ± 9.694 |
| Body mass index (kg/m2) | 27.0 ± 4.9 |
| Smoking | |
| Never | 30 (27.3) |
| Active | 12 (10.9) |
| Quit < 6 weeks prior to surgery | 5 (4.5) |
| Quit 6 weeks to 90 days prior to surgery | 4 (3.6) |
| Quit > 90 days prior to surgery | 59 (53.6) |
| Pack year history | 20 (0-40) |
| Alcohol consumption > 4 standard drinks | 13 (11.8) |
| Risk classification | |
| ASA | |
| 1 | 2 (1.8) |
| 2 | 35 (31.8) |
| 3 | 68 (61.8) |
| 4 | 5 (4.5) |
| ECOG | |
| 0 | 78 (70.9) |
| 1 | 28 (25.5) |
| 2 | 3 (2.7) |
| ACCI (median) | 4 (3-5) |
| Comorbidities | |
| Coronary artery disease | 3 (2.7) |
| Myocardial infarction | 6 (5.5) |
| Congestive heart failure | 1 (0.9) |
| Peripheral vascular disease | 7 (6.4) |
| Cerebrovascular accident | 5 (4.5) |
| Chronic pulmonary disease | 11 (10) |
| Diabetes mellitus (uncomplicated) | 13 (11.8) |
| Diabetes mellitus (end-organ damage) | 2 (1.8) |
| Moderate to severe renal disease | 1 (0.9) |
| Synchronous malignancy (solid tumor) | 2 (1.8) |
| Past malignancy | 16 (14.5) |
| Previous laparotomy | 13 (11.8) |
| Previous thoracotomy | 8 (7.3) |
| Previous hiatal operation | 4 (3.6) |
| Laboratory tests | |
| Hemoglobin (g/L) | 132 (90, 176) |
| White cell ( 109/L) | 6.6 (3, 13) |
| Platelet ( 109/L) | 231.5 (110, 541) |
| Creatinine (mmol/L) | 79.5 (44, 72) |
| eGFR (mL/minute/1.73 m2) | 87 (33, 91) |
| Albumin (g/L) | 38 (27, 44) |
| Principal diagnosis (indication for surgery) | |
| Malignant | 104 (94.5) |
| Benign | 6 (5.5) |
| Surgical approach | |
| Open | 94 (85.4) |
| Minimally invasive (laparoscopy & thoracoscopy) | 3 (2.7) |
| Hybrid (chest or abdomen) | 13 (11.8) |
| Conversion to open | 5 (4.5) |
| Anastomosis site | |
| Chest | 68 (61.8) |
| Neck | 42 (38.2) |
| Esophageal conduit | |
| Stomach | 107 (97.3) |
| Colon | 3 (2.7) |
| AJCC staging (8th edition) | |
| I | 36 (32.7) |
| II | 14 (12.7) |
| IIIA | 10 (9) |
| IIIB | 27 (24.5) |
| IVA | 13 (11.8) |
| IVB | 3 (2.7) |
| Resection margin | |
| R0: Negative | 97 (88.1) |
| R1: Microscopic positive | 10 (9) |
| R2: Macroscopic positive | 1 (0.9) |
| Admission details | |
| ICU length of stay (days) n = 108 | 2.7 (1.6-6.3) |
| HDU length of stay (days) n = 17 | 0.5 (0.4-0.7) |
| Length of hospital stay | 18 (13-27) |
| Discharge destination | |
| Home | 84 (76.4) |
| Hospital at home | 5 (4.5) |
| Rehabilitation facility/subacute care | 19 (17.3) |
| Death | 2 (1.8) |
| Readmission | |
| 30-day readmission | 26 (23.6) |
| 90-day readmission | 47 (42.7) |
- Citation: Buchholz V, Lee DK, Liu DS, Aly A, Barnett SA, Hazard R, Le P, Kioussis B, Muralidharan V, Weinberg L. Cost burden following esophagectomy: A single centre observational study. World J Gastrointest Surg 2024; 16(7): 2255-2269
- URL: https://www.wjgnet.com/1948-9366/full/v16/i7/2255.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i7.2255